Industry stocks

Biotechnology Stocks on NASDAQ

Compare NASDAQ-listed Biotechnology stocks by fair value, valuation, financial quality, profitability, risk, and market outlook.

Sellas Life Sciences Group Inc (SLS)
Fair Value-33.9% Downside Overvalued Analyst312.4% Upside Market Cap1.591 B P/E— Yield0.0% HealthGood
  NASDAQ
Tenax Therapeutics Inc (TENX)
Fair Value35.8% Upside Undervalued Analyst490.5% Upside Market Cap93.37 M P/E— Yield0.0% HealthWeak
  NASDAQ
Vanda Pharmaceuticals Inc (VNDA)
Fair Value38.9% Upside Undervalued Analyst220.3% Upside Market Cap217.1 M P/E— Yield0.0% HealthWeak
  NASDAQ
Vericel Corp Ord (VCEL)
Fair Value-5.9% Downside Fair Analyst15.3% Upside Market Cap2.643 B P/E109.5x Yield0.0% HealthGreat
  NASDAQ
Vertex Pharmaceuticals Inc (VRTX)
Fair Value-8.6% Downside Fair Analyst6.7% Upside Market Cap137.5 B P/E34.6x Yield0.0% HealthGood
  NASDAQ
XOMA Corp (XOMA)
Market Cap710.2 M P/E—
  NASDAQ
Agios Pharm (AGIO)
Fair Value38.3% Upside Undervalued Analyst62.3% Upside Market Cap1.682 B P/E— Yield0.0% HealthFair
  NASDAQ
Akari Therapeutics PLC (AKTX)
Fair Value18.9% Upside Undervalued Analyst229.0% Upside Market Cap17.71 M P/E— Yield0.0% HealthFair
  NASDAQ
Akebia Ther (AKBA)
Fair Value89.7% Upside Bargain Analyst819.4% Upside Market Cap117.9 M P/E— Yield0.0% HealthGood
  NASDAQ
Aldeyra The (ALDX)
Fair Value28.8% Upside Undervalued Analyst971.4% Upside Market Cap37.65 M P/E— Yield0.0% HealthFair
  NASDAQ
Amarin Corporation PLC (AMRN)
Fair Value7.9% Upside Fair Analyst12.3% Upside Market Cap243.9 M P/E— Yield0.0% HealthGood
  NASDAQ
Anavex Life Sciences Corp (AVXL)
Fair Value38.7% Upside Undervalued Market Cap102.9 M P/E— Yield0.0% HealthFair
  NASDAQ
Anixa Biosciences Inc (ANIX)
Fair Value-30.0% Downside Overvalued Analyst219.0% Upside Market Cap105.3 M P/E— Yield0.0% HealthFair
  NASDAQ
Arbutus Biopharma Corp (ABUS)
Fair Value18.1% Upside Undervalued Analyst48.4% Upside Market Cap723.1 M P/E4.7x Yield0.0% HealthGreat
  NASDAQ Featured in Financially Strong Value High-Growth Small-Cap Stocks
Arcturus Therapeutics Holdings Inc (ARCT)
Fair Value29.0% Upside Undervalued Analyst154.3% Upside Market Cap266 M P/E— Yield0.0% HealthFair
  NASDAQ
Ardelyx Inc (ARDX)
Fair Value27.8% Upside Undervalued Analyst328.1% Upside Market Cap747.8 M P/E— Yield0.0% HealthFair
  NASDAQ
Atossa Therapeutics Inc (ATOS)
Fair Value26.6% Upside Undervalued Analyst840.6% Upside Market Cap20.158 M P/E— Yield0.0% HealthWeak
  NASDAQ
Aurinia Pharmaceuticals Inc (AUPH)
Fair Value27.5% Upside Undervalued Analyst12.8% Upside Market Cap2.172 B P/E6.9x Yield0.0% HealthExcellent
  NASDAQ Featured in Financially Strong Value
Avita Medical Ltd (RCEL)
Fair Value-37.0% Downside Overvalued Analyst-14.6% Downside Market Cap484.9 M P/E— Yield0.0% HealthFair
  NASDAQ
Benitec Biopharma Ltd ADR (BNTC)
Fair Value-12.0% Downside Fair Analyst169.5% Upside Market Cap301.4 M P/E— Yield0.0% HealthFair
  NASDAQ
Capricor Therapeutics Inc (CAPR)
Fair Value-1.9% Downside Fair Analyst214.0% Upside Market Cap501.2 M P/E— Yield0.0% HealthFair
  NASDAQ
Cardiff Oncology Inc (CRDF)
Fair Value35.6% Upside Undervalued Analyst732.2% Upside Market Cap58.759 M P/E— Yield0.0% HealthWeak
  NASDAQ Featured in Bullish Trend Stocks
Caredx Inc (CDNA)
Fair Value-25.0% Downside Overvalued Analyst22.5% Upside Market Cap4.01 B P/E31.2x Yield0.0% HealthGreat
  NASDAQ Featured in High-Momentum Stocks Bullish Trend Stocks
Cellectar Biosciences Inc (CLRB)
Fair Value48.9% Upside Undervalued Analyst900.0% Upside Market Cap10.917 M P/E— Yield0.0% HealthFair
  NASDAQ
CervoMed Inc (CRVO)
Fair Value37.4% Upside Undervalued Analyst934.5% Upside Market Cap22.225 M P/E— Yield0.0% HealthWeak
  NASDAQ
Clinuvel Pharmaceuticals Ltd ADR (CUVL)
Fair Value45.7% Upside Undervalued Market Cap270.7 M P/E11.3x Yield0.6% HealthGreat
  NASDAQ
Crescent Biopharma Inc (CBIO)
Fair Value-8.9% Downside Fair Analyst143.4% Upside Market Cap552.3 M P/E— Yield0.0% HealthFair
  NASDAQ
Dyadic International Inc (DYAI)
Fair Value46.7% Upside Undervalued Market Cap12.415 M P/E— Yield0.0% HealthWeak
  NASDAQ
Edesa Biotech Inc (EDSA)
Fair Value20.0% Upside Undervalued Analyst666.8% Upside Market Cap28.915 M P/E— Yield0.0% HealthWeak
  NASDAQ
Eledon Pharmaceuticals Inc (ELDN)
Fair Value-8.1% Downside Fair Analyst265.9% Upside Market Cap199.7 M P/E— Yield0.0% HealthFair
  NASDAQ
Enanta Pharmaceuticals Inc (ENTA)
Fair Value-6.9% Downside Fair Analyst116.6% Upside Market Cap293.7 M P/E— Yield0.0% HealthFair
  NASDAQ
Enlivex Therapeutics Ltd (ENLV)
Fair Value48.2% Upside Undervalued Market Cap1.605 M P/E— Yield0.0% HealthGood
  NASDAQ
Ernexa Therapeutics Inc (ERNA)
Fair Value40.9% Upside Undervalued Market Cap2.987 M P/E— Yield0.0% HealthWeak
  NASDAQ
Evogene Ltd (EVGN)
Fair Value27.2% Upside Undervalued Analyst551.5% Upside Market Cap4.733 M P/E— Yield0.0% HealthWeak
  NASDAQ
Exelixis Inc (EXEL)
Fair Value1.7% Upside Fair Analyst-10.7% Downside Market Cap16.751 B P/E18.9x Yield0.0% HealthExcellent
  NASDAQ
Fate Therapeutics Inc (FATE)
Fair Value9.5% Upside Fair Analyst210.5% Upside Market Cap222.3 M P/E— Yield0.0% HealthFair
  NASDAQ
Galectin Therapeutics Inc (GALT)
Fair Value-40.3% Downside Overvalued Analyst268.5% Upside Market Cap300.5 M P/E— Yield0.0% HealthFair
  NASDAQ
Genmab AS (GMAB)
Fair Value11.4% Upside Fair Analyst23.2% Upside Market Cap32.603 B P/E41.4x Yield0.0% HealthGreat
  NASDAQ
GeoVax Labs Inc (GOVX)
Fair Value35.4% Upside Undervalued Market Cap1.439 M P/E— Yield0.0% HealthWeak
  NASDAQ
GT Biopharma Inc (GTBP)
Fair Value15.3% Upside Fair Market Cap8.12 M P/E— Yield0.0% HealthWeak
  NASDAQ
Heron Therapeuti (HRTX)
Fair Value17.6% Upside Fair Analyst614.3% Upside Market Cap52.817 M P/E— Yield0.0% HealthFair
  NASDAQ
Ibio Inc (IBIO)
Fair Value46.1% Upside Undervalued Analyst679.2% Upside Market Cap46.948 M P/E— Yield0.0% HealthFair
  NASDAQ
Immunic Inc (IMUX)
Fair Value54.1% Upside Bargain Analyst488.7% Upside Market Cap100.6 M P/E— Yield0.0% HealthFair
  NASDAQ
Immutep Ltd ADR (IMMP)
Fair Value91.7% Upside Bargain Market Cap21.463 M P/E— Yield0.0% HealthWeak
  NASDAQ
Inovio Pharmaceuticals Inc (INO)
Fair Value-46.5% Downside Overvalued Analyst267.8% Upside Market Cap149.9 M P/E— Yield0.0% HealthFair
  NASDAQ
Iovance Biotherapeutics Inc (IOVA)
Fair Value24.0% Upside Undervalued Analyst84.8% Upside Market Cap3.49 B P/E— Yield0.0% HealthGood
  NASDAQ Featured in High-Momentum Stocks Bullish Trend Stocks
Kamada Ltd (KMDA)
Fair Value41.8% Upside Undervalued Analyst96.5% Upside Market Cap388.4 M P/E17.5x Yield2.3% HealthGreat
  NASDAQ
Karyopharm Therapeutics Inc (KPTI)
Market Cap1.396 M P/E— Yield0.0% HealthWeak
  NASDAQ
Larimar Therapeutics Inc (LRMR)
Fair Value55.3% Upside Bargain Analyst520.7% Upside Market Cap241.6 M P/E— Yield0.0% HealthWeak
  NASDAQ
Explore listed stocks on NASDAQ with company information and fair value data.